Lat­est news: An­oth­er Alzheimer's 'break­through'?; GSK de­camps from icon­ic HQ; Red light in off-the-shelf CAR-T; Chart­ing biotech's Q3; and more

Wel­come back to End­points Week­ly, your re­view of the week’s top bio­phar­ma head­lines. Want this in your in­box every Sat­ur­day morn­ing? Cur­rent End­points read­ers can vis­it their read­er pro­file to add End­points Week­ly. New to End­points? Sign up here.

R&D strate­gies are cen­tral to any bio­phar­ma com­pa­ny — and es­pe­cial­ly the larg­er ones. John Car­roll has in­vit­ed a stel­lar slate of guests to talk about ex­act­ly that at the Eu­ro­pean Bio­phar­ma Sum­mit com­ing up next week. You can view the line up and re­serve a spot here.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.